« Back to Research Deepdives

Diabetes, Glycaemic Control, and Dementia Risk: Cause or Effect?

This content is restricted to members.

To view our premium content, sign up for a membership:

Register New Account

Username

First Name

Last Name

Password

Password Again

Choose your membership level

Monthly Membership - €24.99 - 1 Month
Full Education Hub access: the weekly Study Deepdive, bi-monthly video Research Lectures, Exclusive Articles, and the full backcatalog of Deepdives in downloadable pdf format.
Annual Membership - €249.99 - 1 Year
Access to all the Education Hub content, at a reduced annual rate.

Discount Code - Valid - Invalid

Choose Your Payment Method

Credit / Debit Card PayPal

I agree to the privacy policy

‹ Back to Research Deepdives

References

1. Merino J, Tobias DK. The unique challenges of studying the genetics of diet and nutrition. Nat Med. 2022 Feb 3;28(2):221–2.
2. Ohukainen P, Virtanen JK, Ala-Korpela M. Vexed causal inferences in nutritional epidemiology—call for genetic help. Int J Epidemiol. 2022 Feb 18;51(1):6-15.
3. van der Flier WM. Epidemiology and risk factors of dementia. J Neurol Neurosurg Psychiatry. 2005 Dec 1;76(suppl_5):v2–7.
4. Xue M, Xu W, Ou YN, Cao XP, Tan MS, Tan L, et al. Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019 Nov;55:100944.
5. Østergaard SD, Mukherjee S, Sharp SJ, Proitsi P, Lotta LA, Day F, et al. Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study. PLoS Med. 2015 Jun 16;12(6):e1001841.
6. Ference BA. Causal Effect of Lipids and Lipoproteins on Atherosclerosis: Lessons from Genomic Studies. Cardiol Clin. 2018;36(2):203–11.
7. Ding J, Davis-Plourde KL, Sedaghat S, Tully PJ, Wang W, Phillips C, et al. Antihypertensive medications and risk for incident dementia and Alzheimer’s disease: a meta-analysis of individual participant data from prospective cohort studies. Lancet Neurol. 2020 Jan;19(1):61–70.
8. James SN, Wong A, Tillin T, Hardy R, Chaturvedi N, Richards M. The effect of mid-life insulin resistance and type 2 diabetes on older-age cognitive state: the explanatory role of early-life advantage. Diabetologia. 2019 Oct 29;62(10):1891–900.
9. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimer’s and Dementia. 2007;3(3):186–91.